Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

弥柠 - NMPA Drug Approval Details

Approvals/NMPA/Desmopressin Acetate Injection

Approved

化学药品

Desmopressin Acetate Injection

Ferring AG🇨🇳 National Medical Products Administration

Approval Date: Mar 17, 2022
Approval ID: 8F2ZxtM7bqu
Company: Ferring AG
Type: 化学药品

Approval Details

Approval Id: 8F2ZxtM7bqu
Approval Number: 国药准字HJ20170093
Generic Name: 醋酸去氨加压素注射液
Generic Name En: Desmopressin Acetate Injection
Trade Name: 弥柠
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 1ml:4μg(按去氨加压素计为3.56μg)
Reg Date: 2022-03-17
Expired Date: 2027-03-16
Company Name: Ferring AG
Production Company Name: Rechon Life Science AB
Company Detail Path: /organization/ferring-ag
Production Company Detail Path: /organization/rechon-life-science-ab

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Mar 17, 2022

Approval ID

8F2ZxtM7bqu

Type

化学药品

Back to NMPA Approvals